{"id":60930,"date":"2022-08-31T16:50:32","date_gmt":"2022-08-31T20:50:32","guid":{"rendered":"https:\/\/www.med.unc.edu\/medicine\/?p=60930"},"modified":"2023-06-06T18:21:38","modified_gmt":"2023-06-06T22:21:38","slug":"sustained-efficacy-of-long-acting-cabotegravir-for-prep-among-cisgender-women-findings-from-hptn-084-study","status":"publish","type":"post","link":"https:\/\/www.med.unc.edu\/medicine\/news\/sustained-efficacy-of-long-acting-cabotegravir-for-prep-among-cisgender-women-findings-from-hptn-084-study\/","title":{"rendered":"Sustained Efficacy of Long-Acting Cabotegravir for PrEP Among Cisgender Women \u2013 Findings from HPTN 084 Study"},"content":{"rendered":"<figure id=\"attachment_3321\" class=\"thumbnail wp-caption alignright\" style=\"width: 310px\"><a href=\"https:\/\/www.med.unc.edu\/medicine\/infdis\/wp-content\/uploads\/sites\/1276\/2022\/05\/MikeCohenNAMheadshotsJCL201-scaled.jpg\"><img loading=\"lazy\" decoding=\"async\" class=\"size-medium wp-image-3321\" src=\"https:\/\/www.med.unc.edu\/medicine\/infdis\/wp-content\/uploads\/sites\/1276\/2022\/05\/MikeCohenNAMheadshotsJCL201-300x200.jpg\" alt=\"MikeCohenNAMheadshotsJCL201\" width=\"300\" height=\"200\" \/><\/a><figcaption class=\"caption wp-caption-text\">Dr. Mike Cohen<\/figcaption><\/figure>\n<p>Researchers from the HIV Prevention Trials Network (HPTN) presented updated results from the <a class=\"link \" href=\"https:\/\/www.globenewswire.com\/Tracker?data=_2q2vJYIZmZkoHIQKM5nNSblar50reqd0tDXt3zBx_5GqFMdZeK5XR5NnP1DE_gDjp713ThDXSwCvlxWQqIBMRB7PmpTjRAJxjnpbYbp2Q0=\" target=\"_blank\" rel=\"nofollow noopener\" data-ylk=\"slk:HPTN 084\" data-rapid_p=\"7\" data-v9y=\"1\">HPTN 084<\/a> long-acting cabotegravir (CAB) for pre-exposure prophylaxis (PrEP) study at the AIDS 2022 conference in Montreal. New findings show reductions in HIV incidence were sustained in the 12 months following trial unblinding (November 5, 2020, through November 5, 2021).<\/p>\n<p><a href=\"https:\/\/globalhealth.unc.edu\/2022\/08\/sustained-efficacy-of-long-acting-cabotegravir-for-prep-among-cisgender-women-findings-from-hptn-084-study\/\">Read more<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Researchers from the HIV Prevention Trials Network (HPTN) presented updated results from the HPTN 084 long-acting cabotegravir (CAB) for pre-exposure prophylaxis (PrEP) study at the AIDS 2022 conference in Montreal. New findings show reductions in HIV incidence were sustained in the 12 months following trial unblinding (November 5, 2020, through November 5, 2021). Read more.<\/p>\n","protected":false},"author":69419,"featured_media":30879,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"layout":"","cellInformation":"","apiCallInformation":"","footnotes":"","_links_to":"","_links_to_target":""},"categories":[640,100],"tags":[631],"class_list":["post-60930","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-fellowship","category-infectious-diseases","tag-631","odd"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Sustained Efficacy of Long-Acting Cabotegravir for PrEP Among Cisgender Women \u2013 Findings from HPTN 084 Study | Department of Medicine<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.med.unc.edu\/medicine\/news\/sustained-efficacy-of-long-acting-cabotegravir-for-prep-among-cisgender-women-findings-from-hptn-084-study\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Sustained Efficacy of Long-Acting Cabotegravir for PrEP Among Cisgender Women \u2013 Findings from HPTN 084 Study | Department of Medicine\" \/>\n<meta property=\"og:description\" content=\"Researchers from the HIV Prevention Trials Network (HPTN) presented updated results from the HPTN 084 long-acting cabotegravir (CAB) for pre-exposure prophylaxis (PrEP) study at the AIDS 2022 conference in Montreal. New findings show reductions in HIV incidence were sustained in the 12 months following trial unblinding (November 5, 2020, through November 5, 2021). Read more.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.med.unc.edu\/medicine\/news\/sustained-efficacy-of-long-acting-cabotegravir-for-prep-among-cisgender-women-findings-from-hptn-084-study\/\" \/>\n<meta property=\"og:site_name\" content=\"Department of Medicine\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/UNCDeptMedicine\" \/>\n<meta property=\"article:published_time\" content=\"2022-08-31T20:50:32+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-06-06T22:21:38+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2019\/04\/MikeCohenNAMheadshotsJCL201-scaled-e1642130048312.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1523\" \/>\n\t<meta property=\"og:image:height\" content=\"1708\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Kim Morris\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@uncdeptmedicine\" \/>\n<meta name=\"twitter:site\" content=\"@uncdeptmedicine\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Kim Morris\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.med.unc.edu\/medicine\/news\/sustained-efficacy-of-long-acting-cabotegravir-for-prep-among-cisgender-women-findings-from-hptn-084-study\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.med.unc.edu\/medicine\/news\/sustained-efficacy-of-long-acting-cabotegravir-for-prep-among-cisgender-women-findings-from-hptn-084-study\/\"},\"author\":{\"name\":\"Kim Morris\",\"@id\":\"https:\/\/www.med.unc.edu\/medicine\/#\/schema\/person\/9a358414a53d5237f9ba3f8daa55c529\"},\"headline\":\"Sustained Efficacy of Long-Acting Cabotegravir for PrEP Among Cisgender Women \u2013 Findings from HPTN 084 Study\",\"datePublished\":\"2022-08-31T20:50:32+00:00\",\"dateModified\":\"2023-06-06T22:21:38+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.med.unc.edu\/medicine\/news\/sustained-efficacy-of-long-acting-cabotegravir-for-prep-among-cisgender-women-findings-from-hptn-084-study\/\"},\"wordCount\":72,\"image\":{\"@id\":\"https:\/\/www.med.unc.edu\/medicine\/news\/sustained-efficacy-of-long-acting-cabotegravir-for-prep-among-cisgender-women-findings-from-hptn-084-study\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2019\/04\/MikeCohenNAMheadshotsJCL201-scaled-e1642130048312.jpg\",\"keywords\":[\"2022\"],\"articleSection\":[\"Fellowship\",\"Infectious Diseases\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.med.unc.edu\/medicine\/news\/sustained-efficacy-of-long-acting-cabotegravir-for-prep-among-cisgender-women-findings-from-hptn-084-study\/\",\"url\":\"https:\/\/www.med.unc.edu\/medicine\/news\/sustained-efficacy-of-long-acting-cabotegravir-for-prep-among-cisgender-women-findings-from-hptn-084-study\/\",\"name\":\"Sustained Efficacy of Long-Acting Cabotegravir for PrEP Among Cisgender Women \u2013 Findings from HPTN 084 Study | Department of Medicine\",\"isPartOf\":{\"@id\":\"https:\/\/www.med.unc.edu\/medicine\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.med.unc.edu\/medicine\/news\/sustained-efficacy-of-long-acting-cabotegravir-for-prep-among-cisgender-women-findings-from-hptn-084-study\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.med.unc.edu\/medicine\/news\/sustained-efficacy-of-long-acting-cabotegravir-for-prep-among-cisgender-women-findings-from-hptn-084-study\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2019\/04\/MikeCohenNAMheadshotsJCL201-scaled-e1642130048312.jpg\",\"datePublished\":\"2022-08-31T20:50:32+00:00\",\"dateModified\":\"2023-06-06T22:21:38+00:00\",\"author\":{\"@id\":\"https:\/\/www.med.unc.edu\/medicine\/#\/schema\/person\/9a358414a53d5237f9ba3f8daa55c529\"},\"breadcrumb\":{\"@id\":\"https:\/\/www.med.unc.edu\/medicine\/news\/sustained-efficacy-of-long-acting-cabotegravir-for-prep-among-cisgender-women-findings-from-hptn-084-study\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.med.unc.edu\/medicine\/news\/sustained-efficacy-of-long-acting-cabotegravir-for-prep-among-cisgender-women-findings-from-hptn-084-study\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.med.unc.edu\/medicine\/news\/sustained-efficacy-of-long-acting-cabotegravir-for-prep-among-cisgender-women-findings-from-hptn-084-study\/#primaryimage\",\"url\":\"https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2019\/04\/MikeCohenNAMheadshotsJCL201-scaled-e1642130048312.jpg\",\"contentUrl\":\"https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2019\/04\/MikeCohenNAMheadshotsJCL201-scaled-e1642130048312.jpg\",\"width\":1523,\"height\":1708,\"caption\":\"Myron Cohen, MD\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.med.unc.edu\/medicine\/news\/sustained-efficacy-of-long-acting-cabotegravir-for-prep-among-cisgender-women-findings-from-hptn-084-study\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.med.unc.edu\/medicine\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Sustained Efficacy of Long-Acting Cabotegravir for PrEP Among Cisgender Women \u2013 Findings from HPTN 084 Study\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.med.unc.edu\/medicine\/#website\",\"url\":\"https:\/\/www.med.unc.edu\/medicine\/\",\"name\":\"Department of Medicine\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.med.unc.edu\/medicine\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.med.unc.edu\/medicine\/#\/schema\/person\/9a358414a53d5237f9ba3f8daa55c529\",\"name\":\"Kim Morris\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.med.unc.edu\/medicine\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/95c34b3e4d55a602b94260bccc6350c2ddfdde901530a734fe6c8fa9e3a5d399?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/95c34b3e4d55a602b94260bccc6350c2ddfdde901530a734fe6c8fa9e3a5d399?s=96&d=mm&r=g\",\"caption\":\"Kim Morris\"},\"description\":\"Medicine - Dept of\",\"url\":\"https:\/\/www.med.unc.edu\/medicine\/news\/author\/kcmorris\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Sustained Efficacy of Long-Acting Cabotegravir for PrEP Among Cisgender Women \u2013 Findings from HPTN 084 Study | Department of Medicine","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.med.unc.edu\/medicine\/news\/sustained-efficacy-of-long-acting-cabotegravir-for-prep-among-cisgender-women-findings-from-hptn-084-study\/","og_locale":"en_US","og_type":"article","og_title":"Sustained Efficacy of Long-Acting Cabotegravir for PrEP Among Cisgender Women \u2013 Findings from HPTN 084 Study | Department of Medicine","og_description":"Researchers from the HIV Prevention Trials Network (HPTN) presented updated results from the HPTN 084 long-acting cabotegravir (CAB) for pre-exposure prophylaxis (PrEP) study at the AIDS 2022 conference in Montreal. New findings show reductions in HIV incidence were sustained in the 12 months following trial unblinding (November 5, 2020, through November 5, 2021). Read more.","og_url":"https:\/\/www.med.unc.edu\/medicine\/news\/sustained-efficacy-of-long-acting-cabotegravir-for-prep-among-cisgender-women-findings-from-hptn-084-study\/","og_site_name":"Department of Medicine","article_publisher":"https:\/\/www.facebook.com\/UNCDeptMedicine","article_published_time":"2022-08-31T20:50:32+00:00","article_modified_time":"2023-06-06T22:21:38+00:00","og_image":[{"width":1523,"height":1708,"url":"https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2019\/04\/MikeCohenNAMheadshotsJCL201-scaled-e1642130048312.jpg","type":"image\/jpeg"}],"author":"Kim Morris","twitter_card":"summary_large_image","twitter_creator":"@uncdeptmedicine","twitter_site":"@uncdeptmedicine","twitter_misc":{"Written by":"Kim Morris","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.med.unc.edu\/medicine\/news\/sustained-efficacy-of-long-acting-cabotegravir-for-prep-among-cisgender-women-findings-from-hptn-084-study\/#article","isPartOf":{"@id":"https:\/\/www.med.unc.edu\/medicine\/news\/sustained-efficacy-of-long-acting-cabotegravir-for-prep-among-cisgender-women-findings-from-hptn-084-study\/"},"author":{"name":"Kim Morris","@id":"https:\/\/www.med.unc.edu\/medicine\/#\/schema\/person\/9a358414a53d5237f9ba3f8daa55c529"},"headline":"Sustained Efficacy of Long-Acting Cabotegravir for PrEP Among Cisgender Women \u2013 Findings from HPTN 084 Study","datePublished":"2022-08-31T20:50:32+00:00","dateModified":"2023-06-06T22:21:38+00:00","mainEntityOfPage":{"@id":"https:\/\/www.med.unc.edu\/medicine\/news\/sustained-efficacy-of-long-acting-cabotegravir-for-prep-among-cisgender-women-findings-from-hptn-084-study\/"},"wordCount":72,"image":{"@id":"https:\/\/www.med.unc.edu\/medicine\/news\/sustained-efficacy-of-long-acting-cabotegravir-for-prep-among-cisgender-women-findings-from-hptn-084-study\/#primaryimage"},"thumbnailUrl":"https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2019\/04\/MikeCohenNAMheadshotsJCL201-scaled-e1642130048312.jpg","keywords":["2022"],"articleSection":["Fellowship","Infectious Diseases"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.med.unc.edu\/medicine\/news\/sustained-efficacy-of-long-acting-cabotegravir-for-prep-among-cisgender-women-findings-from-hptn-084-study\/","url":"https:\/\/www.med.unc.edu\/medicine\/news\/sustained-efficacy-of-long-acting-cabotegravir-for-prep-among-cisgender-women-findings-from-hptn-084-study\/","name":"Sustained Efficacy of Long-Acting Cabotegravir for PrEP Among Cisgender Women \u2013 Findings from HPTN 084 Study | Department of Medicine","isPartOf":{"@id":"https:\/\/www.med.unc.edu\/medicine\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.med.unc.edu\/medicine\/news\/sustained-efficacy-of-long-acting-cabotegravir-for-prep-among-cisgender-women-findings-from-hptn-084-study\/#primaryimage"},"image":{"@id":"https:\/\/www.med.unc.edu\/medicine\/news\/sustained-efficacy-of-long-acting-cabotegravir-for-prep-among-cisgender-women-findings-from-hptn-084-study\/#primaryimage"},"thumbnailUrl":"https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2019\/04\/MikeCohenNAMheadshotsJCL201-scaled-e1642130048312.jpg","datePublished":"2022-08-31T20:50:32+00:00","dateModified":"2023-06-06T22:21:38+00:00","author":{"@id":"https:\/\/www.med.unc.edu\/medicine\/#\/schema\/person\/9a358414a53d5237f9ba3f8daa55c529"},"breadcrumb":{"@id":"https:\/\/www.med.unc.edu\/medicine\/news\/sustained-efficacy-of-long-acting-cabotegravir-for-prep-among-cisgender-women-findings-from-hptn-084-study\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.med.unc.edu\/medicine\/news\/sustained-efficacy-of-long-acting-cabotegravir-for-prep-among-cisgender-women-findings-from-hptn-084-study\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.med.unc.edu\/medicine\/news\/sustained-efficacy-of-long-acting-cabotegravir-for-prep-among-cisgender-women-findings-from-hptn-084-study\/#primaryimage","url":"https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2019\/04\/MikeCohenNAMheadshotsJCL201-scaled-e1642130048312.jpg","contentUrl":"https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2019\/04\/MikeCohenNAMheadshotsJCL201-scaled-e1642130048312.jpg","width":1523,"height":1708,"caption":"Myron Cohen, MD"},{"@type":"BreadcrumbList","@id":"https:\/\/www.med.unc.edu\/medicine\/news\/sustained-efficacy-of-long-acting-cabotegravir-for-prep-among-cisgender-women-findings-from-hptn-084-study\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.med.unc.edu\/medicine\/"},{"@type":"ListItem","position":2,"name":"Sustained Efficacy of Long-Acting Cabotegravir for PrEP Among Cisgender Women \u2013 Findings from HPTN 084 Study"}]},{"@type":"WebSite","@id":"https:\/\/www.med.unc.edu\/medicine\/#website","url":"https:\/\/www.med.unc.edu\/medicine\/","name":"Department of Medicine","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.med.unc.edu\/medicine\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.med.unc.edu\/medicine\/#\/schema\/person\/9a358414a53d5237f9ba3f8daa55c529","name":"Kim Morris","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.med.unc.edu\/medicine\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/95c34b3e4d55a602b94260bccc6350c2ddfdde901530a734fe6c8fa9e3a5d399?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/95c34b3e4d55a602b94260bccc6350c2ddfdde901530a734fe6c8fa9e3a5d399?s=96&d=mm&r=g","caption":"Kim Morris"},"description":"Medicine - Dept of","url":"https:\/\/www.med.unc.edu\/medicine\/news\/author\/kcmorris\/"}]}},"featured_image":"https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2019\/04\/MikeCohenNAMheadshotsJCL201-scaled-e1642130048312.jpg","featured_image_medium":"https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2019\/04\/MikeCohenNAMheadshotsJCL201-scaled-e1642130048312-268x300.jpg","featured_image_medium_large":"https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2019\/04\/MikeCohenNAMheadshotsJCL201-scaled-e1642130048312-768x861.jpg","featured_image_large":"https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2019\/04\/MikeCohenNAMheadshotsJCL201-scaled-e1642130048312-913x1024.jpg","featured_image_thumbnail":"https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2019\/04\/MikeCohenNAMheadshotsJCL201-scaled-e1642130048312-150x150.jpg","featured_image_alt":"Myron Cohen, MD-ID-faculty-in-covid-news-dec-24-30","category_details":[{"name":"Fellowship","link":"https:\/\/www.med.unc.edu\/medicine\/news\/category\/fellowship\/"},{"name":"Infectious Diseases","link":"https:\/\/www.med.unc.edu\/medicine\/news\/category\/infectious-diseases\/"}],"tag_details":[{"name":"2022","link":"https:\/\/www.med.unc.edu\/medicine\/news\/tag\/2022\/"}],"_links_to":[],"_links_to_target":[],"_links":{"self":[{"href":"https:\/\/www.med.unc.edu\/medicine\/wp-json\/wp\/v2\/posts\/60930","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.med.unc.edu\/medicine\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.med.unc.edu\/medicine\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.med.unc.edu\/medicine\/wp-json\/wp\/v2\/users\/69419"}],"replies":[{"embeddable":true,"href":"https:\/\/www.med.unc.edu\/medicine\/wp-json\/wp\/v2\/comments?post=60930"}],"version-history":[{"count":0,"href":"https:\/\/www.med.unc.edu\/medicine\/wp-json\/wp\/v2\/posts\/60930\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.med.unc.edu\/medicine\/wp-json\/wp\/v2\/media\/30879"}],"wp:attachment":[{"href":"https:\/\/www.med.unc.edu\/medicine\/wp-json\/wp\/v2\/media?parent=60930"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.med.unc.edu\/medicine\/wp-json\/wp\/v2\/categories?post=60930"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.med.unc.edu\/medicine\/wp-json\/wp\/v2\/tags?post=60930"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}